openPR Logo
Press release

mRNA Vaccines and RNAi Therapeutics Market Will Turn over $12.31 Bn to success Revenue to Cross 31.3 % in the Forecast Period

12-08-2022 05:58 PM CET | Health & Medicine

Press release from: Allied Market Research

mRNA Vaccines and RNAi Therapeutics Market

mRNA Vaccines and RNAi Therapeutics Market

Allied Market Research published a report, titled, '๐ฆ๐‘๐๐€๐•๐š๐œ๐œ๐ข๐ง๐ž๐ฌ ๐š๐ง๐ ๐‘๐๐€๐ข ๐“๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐›๐ฒ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐“๐ฒ๐ฉ๐ž (๐‡๐ž๐ซ๐ž๐๐ข๐ญ๐š๐ซ๐ฒ ๐ญ๐ซ๐š๐ง๐ฌ๐ญ๐ก๐ฒ๐ซ๐ž๐ญ๐ข๐ง-๐ฆ๐ž๐๐ข๐š๐ญ๐ž๐ ๐š๐ฆ๐ฒ๐ฅ๐จ๐ข๐๐จ๐ฌ๐ข๐ฌ ๐ ๐ž๐ง๐ž๐ญ๐ข๐œ, ๐€๐œ๐ฎ๐ญ๐ž ๐ก๐ž๐ฉ๐š๐ญ๐ข๐œ ๐ฉ๐จ๐ซ๐ฉ๐ก๐ฒ๐ซ๐ข๐š, ๐๐ซ๐ข๐ฆ๐š๐ซ๐ฒ ๐ก๐ฒ๐ฉ๐ž๐ซ๐จ๐ฑ๐š๐ฅ๐ฎ๐ซ๐ข๐š ๐ญ๐ฒ๐ฉ๐ž 1, ๐€๐ญ๐ก๐ž๐ซ๐จ๐ฌ๐œ๐ฅ๐ž๐ซ๐จ๐ญ๐ข๐œ ๐œ๐š๐ซ๐๐ข๐จ๐ฏ๐š๐ฌ๐œ๐ฎ๐ฅ๐š๐ซ ๐๐ข๐ฌ๐ž๐š๐ฌ๐ž), ๐›๐ฒ ๐‘๐จ๐ฎ๐ญ๐ž ๐จ๐Ÿ ๐š๐๐ฆ๐ข๐ง๐ข๐ฌ๐ญ๐ซ๐š๐ญ๐ข๐จ๐ง (๐ˆ๐• ๐ข๐ง๐Ÿ๐ฎ๐ฌ๐ข๐จ๐ง, ๐’๐ฎ๐›๐œ๐ฎ๐ญ๐š๐ง๐ž๐จ๐ฎ๐ฌ), ๐›๐ฒ ๐„๐ง๐ ๐ฎ๐ฌ๐ž๐ซ (๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐ˆ๐ง๐ฌ๐ญ๐ข๐ญ๐ฎ๐ญ๐ž๐ฌ, ๐‡๐จ๐ฌ๐ฉ๐ข๐ญ๐š๐ฅ๐ฌ ๐š๐ง๐ ๐œ๐ฅ๐ข๐ง๐ข๐œ๐ฌ): ๐†๐ฅ๐จ๐›๐š๐ฅ ๐Ž๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ฒ ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ ๐š๐ง๐ ๐ˆ๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐…๐จ๐ซ๐ž๐œ๐š๐ฌ๐ญ, 2022-2031.' According to the report, the global mRNA vaccines and RNAi therapeutics industry generated $707.97 million in 2021, and is anticipated to generate $12.31 billion by 2031, witnessing a CAGR of 31.3% from 2022 to 2031.

๐ƒ๐จ๐ฐ๐ง๐ฅ๐จ๐š๐ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ (245 ๐๐š๐ ๐ž๐ฌ ๐๐ƒ๐… ๐ฐ๐ข๐ญ๐ก ๐ˆ๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ, ๐‚๐ก๐š๐ซ๐ญ๐ฌ, ๐“๐š๐›๐ฅ๐ž๐ฌ, ๐…๐ข๐ ๐ฎ๐ซ๐ž๐ฌ): https://www.alliedmarketresearch.com/request-sample/17623

๐‹๐ž๐š๐๐ข๐ง๐  ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ: -

Alnylam Pharmaceuticals
BioNTech AG
Curevac AG
Etherna Immunotherapies
Ethris GMBH
IN-CELL-ART
Moderna Therapeutics
Sangamo Therapeutics, Inc.
Sanofi AG
SCM Life Sciences (Argos Therapeutics, Inc.
Sarepta Therapeutics
Arcturus Therapeutics
Ionis Pharmaceuticals, Inc
Nutcracker
Tiba Biotech

๐…๐‘๐„๐๐”๐„๐๐“๐‹๐˜ ๐€๐’๐Š๐„๐ƒ ๐๐”๐„๐’๐“๐ˆ๐Ž๐๐’?

Q1. What is the total market value of mRNA Vaccine and RNAi Therapeutics Market report ?
Q2. What would be forecast period in the market report?
Q3. What is the market value of mRNA Vaccine and RNAi Therapeutics Market in 2031?
Q4. Which is base year calculated in the mRNA Vaccine and RNAi Therapeutics Market report?
Q5. Which are the top companies hold the market share in mRNA and RNAi Therapeutics market?
Q6. Which is the most influencing segment growing in the mRNA Vaccine and RNAi Therapeutics Market report?
Q7. What are the key trends in the mRNA Vaccine and RNAi Therapeutics Market report?

๐’๐ฉ๐ž๐œ๐ข๐Ÿ๐ข๐œ ๐‘๐ž๐ช๐ฎ๐ข๐ซ๐ž๐ฆ๐ž๐ง๐ญ ๐จ๐ง ๐‚๐Ž๐•๐ˆ๐ƒ-19? ๐€๐ฌ๐ค ๐ญ๐จ ๐Ž๐ฎ๐ซ ๐ˆ๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐„๐ฑ๐ฉ๐ž๐ซ๐ญ: https://www.alliedmarketresearch.com/request-for-customization/17623?reqfor=covid

๐“๐ซ๐ž๐ง๐๐ข๐ง๐  ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ ๐ข๐ง ๐‡๐ž๐š๐ฅ๐ญ๐ก๐œ๐š๐ซ๐ž ๐ˆ๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ:

๐‚๐จ๐ฆ๐ฉ๐จ๐ฎ๐ง๐๐ข๐ง๐  ๐๐ก๐š๐ซ๐ฆ๐š๐œ๐ข๐ž๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก - 2031 https://www.alliedmarketresearch.com/compounding-pharmacies-market-A11920

๐’๐œ๐š๐ซ ๐“๐ซ๐ž๐š๐ญ๐ฆ๐ž๐ง๐ญ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก, 2031 https://www.alliedmarketresearch.com/scar-treatment-market-A13439

๐Œ๐š๐ฌ๐ญ๐จ๐ฉ๐ž๐ฑ๐ฒ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก, 2031 https://www.alliedmarketresearch.com/mastopexy-market-A16849

๐Ž๐ซ๐ ๐š๐ง๐จ๐ข๐๐ฌ ๐š๐ง๐ ๐’๐ฉ๐ก๐ž๐ซ๐จ๐ข๐๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก, 2031 https://www.alliedmarketresearch.com/organoids-and-spheroids-market-A17036

About Us -

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various research data tables and confirms utmost accuracy in our market forecasting. Each and every us companies and this helps us in digging out market data that helps us generate accurate y data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release mRNA Vaccines and RNAi Therapeutics Market Will Turn over $12.31 Bn to success Revenue to Cross 31.3 % in the Forecast Period here

News-ID: 2841277 • Views: โ€ฆ

More Releases from Allied Market Research

Global Urinary Drainage Bags Market: Trends, Growth, and Insights to 2031
Global Urinary Drainage Bags Market: Trends, Growth, and Insights to 2031
The global urinary drainage bags market is experiencing robust growth, with its market size valued at $1.4billion in 2021 and projected to reach $2billion by 2031. This expansion represents a compound annual growth rate (CAGR) of 3.8% from 2021 to 2031, highlighting the increasing demand for these essential medical devices. Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/A17529 What Are Urinary Drainage Bags? Urinary drainage bags are specialized medical devices designed to collectโ€ฆ
Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
The global cream powder industry was estimated at $4.8 billion in 2021 and is expected to hit $8.9 billion by 2031, registering a CAGR of 6.4% from 2022 to 2031. The cream powder market is experiencing growth due to various factors, including the increasing popularity of bakeries and HoReCa (hotels, restaurants, and cafes) and rising consumer demand for natural products. The dairy-based segment is a significant contributor to the market's growthโ€ฆ
Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Billion by 2030; Growing at a CAGR of 17.2%
Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Bil โ€ฆ
The global micro drone industry generated $6.71 billion in 2020, and is expected to reach $28.91 billion in 2030, witnessing a CAGR of 17.2% from 2021 to 2030. The report provides an extensive analysis of changing market dynamics, top segments, top investment pockets, regional landscape, value chain, and competitive scenario. Increased operational efficiency and rise in demand for improved surveillance drive the growth of the global micro drone market. However, strictโ€ฆ
Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of 5.6%
Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of โ€ฆ
The global microwaveable foods industry was accounted for $120.45 billion in 2020, and is expected to reach $230.93 billion by 2031, growing at a CAGR of 5.6% from 2022 to 2031. Rise in popularity of fast-food restaurants and large population base coupled with increase in number of quick-service restaurants drive the global microwaveable foods market. However, lack of awareness about microwavable foods hinders the market growth. On the contrary, rise inโ€ฆ

All 5 Releases


More Releases for Therapeutics

Adrenomyeloneuropathy Market: Epidemiology, Therapies, Companies, DelveInsight | โ€ฆ
Adrenomyeloneuropathy emerging therapies are expected to boost the Adrenomyeloneuropathy Market in the upcoming years. DelveInsight has launched a new report on "Adrenomyeloneuropathy - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Adrenomyeloneuropathy, historical and forecasted epidemiology as well as the Adrenomyeloneuropathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Discover about the Adrenomyeloneuropathy market report @ https://www.delveinsight.com/report-store/adrenomyeloneuropathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr Some of theโ€ฆ
Pompe Disease Market: Epidemiology, Therapies, Companies, DelveInsight | Genzyme โ€ฆ
Pompe Disease emerging therapies, such as MYOZYME (alglucosidase alfa), LUMIZYME, AAV2/8-LSPhGAA, Avalglucosidase alfa, and others, are expected to boost the Pompe Disease Market in the upcoming years. DelveInsight has launched a new report on "Pompe Disease - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Pompe Disease, historical and forecasted epidemiology as well as the Pompe Disease market trends in the United States, EU5 (Germany, Spain,โ€ฆ
Dark Genome Therapeutics Market Deep Research Report with Forecast to 2032 | myN โ€ฆ
The qualitative latest Research report (2025-2032) on the Dark Genome Therapeutics Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves. Request a Sample Copy: https://www.coherentmarketresearch.com/samplepages/133611 Focused on growthโ€ฆ
Hodgkin's lymphoma Therapeutics Market Size Report 2032 | Affimed Therapeutics, โ€ฆ
DelveInsight's "Hodgkin's Lymphoma Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Hodgkin's Lymphoma, historical and forecasted epidemiology as well as the Hodgkin's Lymphoma market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United kingdom and Japan. Discover Key Insights into the Hodgkin's lymphoma Market with DelveInsight's In-Depth Report @ Hodgkin's lymphoma Market Size- https://www.delveinsight.com/sample-request/hodgkins-lymphoma-hl-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr Key Takeaways from the Hodgkin'sโ€ฆ
CRISPR Therapies Pipeline 2024 | Intellia Therapeutics, CRISPR therapeutics, Rep โ€ฆ
DelveInsight's, "CRISPR Therapies Pipeline Insight 2024" report provides comprehensive insights about 25+ CRISPR Therapies Companies and 30+ pipeline drugs in CRISPR Therapies pipeline landscape. It covers the CRISPR Therapies pipeline drug profiles, including clinical and nonclinical stage products. It also covers the CRISPR Therapies therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive CRISPR Therapies pipeline products in this space. Key Takeaways fromโ€ฆ
Digital Therapeutics Market, Digital Therapeutics Market Size, Digital Therapeut โ€ฆ
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025. North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significantโ€ฆ